Ho Pak-Leung
Centre of Infection and Department of Microbiology, Faculty of Medicine, University of Hong Kong, People's Republic of China.
Crit Care Med. 2003 Apr;31(4):1175-82. doi: 10.1097/01.CCM.0000059437.01924.97.
To measure patients' risk for acquiring antibiotic-resistant microorganisms associated with intensive care unit admission.
Prospective, observational study.
Ten public hospitals including one university medical center.
Consecutive patients admitted to ten intensive care units.
Serial patient surveillance cultures were screened for vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus (MRSA), ceftazidime-resistant Gram-negative bacilli (CR-GNB), Acute Physiology and Chronic Health Evaluation II score, and antibiotic and medical device exposures.
A total of 1,697 patient admissions in ten intensive care units were enrolled. The overall carriage rate of antibiotic-resistant bacteria at intensive care unit entry was 12.1% for MRSA, 14% for CR-GNB and 4.7% for both. At discharge from the intensive care unit, new carriage of MRSA, CR-GNB, and both was found in 11.1%, 14.2%, and 2.4% of the patients, respectively. The acquisition rates in the individual units correlated highly and positively with proportion of patients with carriage at intensive care unit entry for both MRSA (n = 10, Pearson's r =.89, p < 0.001) and CR-GNB (n = 10, Pearson's r =.92, p < 0.001). By logistic regression, severity of illness (odds ratio, 1.4), length of stay (odds ratio, 1.7), use of penicillins (odds ratio, 1.9), and number of antibiotics (odds ratio, 1.2) and medical devices (odds ratio, 1.2) were independently associated with intensive care unit acquisition of MRSA. In comparison, variables independently associated with intensive care unit acquisition of CR-GNB were Acute Physiology and Chronic Health Evaluation II score (odds ratio, 1.5), number of antibiotics (odds ratio, 1.1), and artificial airway (odds ratio, 1.5).
These data suggest that hospitalization in the intensive care unit introduces significant risk to patients in terms of transmission of MRSA and/or CR-GNB. This risk seems to be influenced strongly by the proportion of patients with colonization at intensive care unit admission and is associated with severity of illness, length of stay, and exposures to antibiotics and medical devices.
评估重症监护病房(ICU)入院患者感染耐抗生素微生物的风险。
前瞻性观察性研究。
包括一家大学医学中心在内的十家公立医院。
连续入住十个重症监护病房的患者。
对患者进行系列监测培养,以筛查耐万古霉素肠球菌、耐甲氧西林金黄色葡萄球菌(MRSA)、耐头孢他啶革兰阴性杆菌(CR-GNB)、急性生理与慢性健康状况评分II,以及抗生素和医疗器械暴露情况。
十个重症监护病房共纳入1697例入院患者。ICU入院时耐抗生素细菌的总体携带率为:MRSA为12.1%,CR-GNB为14%,两者均为4.7%。在ICU出院时,分别有11.1%、14.2%和2.4%的患者新携带MRSA、CR-GNB以及两者。各科室的获得率与ICU入院时携带菌患者的比例高度正相关,MRSA(n = 10,Pearson相关系数r = 0.89,p < 0.001)和CR-GNB(n = 10,Pearson相关系数r = 0.92,p < 0.001)均如此。通过逻辑回归分析,疾病严重程度(比值比,1.4)、住院时间(比值比,1.7)、青霉素使用情况(比值比,1.9)、抗生素数量(比值比,1.2)和医疗器械数量(比值比,1.2)与ICU获得MRSA独立相关。相比之下,与ICU获得CR-GNB独立相关的变量为急性生理与慢性健康状况评分II(比值比,1.5)、抗生素数量(比值比,1.1)和人工气道(比值比,1.5)。
这些数据表明,在ICU住院会给患者带来感染MRSA和/或CR-GNB的重大风险。这种风险似乎受ICU入院时定植患者比例的强烈影响,并与疾病严重程度、住院时间以及抗生素和医疗器械暴露有关。